Nicky(Tanos)KelepourisMD

PubMed

• Insights from an advisory board: Facilitating transition of care into adulthood in brain cancer survivors with acquired pediatric growth hormone deficiency.
  Craig Alter, Margaret Boguszewski, David Clemmons, Georgiana A Dobri, Mitchell E Geffner, Nicky Kelepouris, Bradley S Miller, Richard Oh, Heidi Shea, Kevin C J Yuen> ;Growth Hormone & IGF Research. 2024 Feb 1
• Coverage of education and training of traumatic brain injury-induced growth hormone deficiency in US residency and fellowship programs: a cross-sectional study.
  Cárdenas, J., Adiga, R., Yuen, K., Kelepouris, N.> ;BMC Medical Education. 2024 Jan 10
• Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database Analysis.
  Kevin C J Yuen, Lewis S Blevins, David R Clemmons, Mads Faurby, Andrew R Hoffman, Nicky Kelepouris, Janice M Kerr, Jens Magelund Tarp, Maria Fleseriu> ;Clinicoeconomics and Outcomes Research. 2024 Jan 1
• 2 citations
  Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER.
  Beverly M K Biller, Charlotte Höybye, Jean-Marc Ferran, Nicky Kelepouris, Navid Nedjatian, Anne Helene Olsen, Matthias M Weber, Murray B Gordon> ;Journal of the Endocrine Society. 2023 May 5
• Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet® IOS and Answer Program.
  Philippe Backeljauw, Joanne C Blair, Jean-Marc Ferran, Nicky Kelepouris, Bradley S Miller, Alberto Pietropoli, Michel Polak, Lars Sävendahl, Franciska Verlinde, Tilman...> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Sep 18
• 1 citations
  Factors Associated With Response to Growth Hormone in Pediatric Growth Disorders: Results of a 5-year Registry Analysis.
  Judith Ross, Moshe Fridman, Nicky Kelepouris, Kristine Murray, Nils Krone, Michel Polak, Tilman R Rohrer, Alberto Pietropoli, Neil Lawrence, Philippe Backeljauw> ;Journal of the Endocrine Society. 2023 Mar 6
• 2 citations
  Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies.
  Charlotte Höybye, Beverly M K Biller, Jean-Marc Ferran, Murray B Gordon, Nicky Kelepouris, Navid Nedjatian, Anne H Olsen, Matthias M Weber> ;Endocrine Connections. 2023 Jan 1
• 1 citations
  Early Growth Hormone Initiation Leads to Favorable Long-Term Growth Outcomes in Children Born Small for Gestational Age.
  Anders Juul, Philippe Backeljauw, Marco Cappa, Alberto Pietropoli, Nicky Kelepouris, Agnès Linglart, Roland Pfäffle, Mitchell Geffner> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Apr 13
• 6 citations
  A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury.
  Kevin C J Yuen, Brent Masel, Michael S Jaffee, Gregory O'Shanick, Tamara L Wexler, Kent Reifschneider, Randall J Urban, Sophie Hoang, Nicky Kelepouris, Andrew R Hoffman> ;Growth Hormone & IGF Research. 2022 Oct 1
• 3 citations
  Adult Growth Hormone Deficiency: Diagnostic and Treatment Journeys From the Patients' Perspective.
  Andrew R Hoffman, Tracy Mathison, Deno Andrews, Kristine Murray, Nicky Kelepouris, Maria Fleseriu> ;Journal of the Endocrine Society. 2022 Jul 1
• 1 citations
  Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status.
  Alexander A L Jorge, Thomas Edouard, Mohamad Maghnie, Alberto Pietropoli, Nicky Kelepouris, Alicia Romano, Martin Zenker, Reiko Horikawa> ;Endocrine Connections. 2022 Apr 15
• 5 citations
  Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence.
  Alicia Romano, Juan Pablo Kaski, Jovanna Dahlgren, Nicky Kelepouris, Alberto Pietropoli, Tilman R Rohrer, Michel Polak> ;Endocrine Connections. 2022 Jan 31
• 1 citations
  Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database.
  Kevin C J Yuen, Anna Camilla Birkegard, Lewis S Blevins, David R Clemmons, Andrew R Hoffman, Nicky Kelepouris, Janice M Kerr, Jens M Tarp, Maria Fleseriu> ;International Journal of Endocrinology. 2022 Jan 1
• 20 citations
  Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER.
  Lars Sävendahl, Michel Polak, Philippe Backeljauw, Joanne C. Blair, Bradley S. Miller, Tilman R Rohrer, Anita C. S. Hokken-Koelega, Alberto Pietropoli, Nicky Kelepouri...> ;The Journal of Clinical Endocrinology and Metabolism. 2021 May 13
• 5 citations
  Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Stud...
  Beverly M. K. Biller, Charlotte Höybye, Paul V. Carroll, Murray B. Gordon, Anna Camilla Birkegård, Nicky Kelepouris, Navid Nedjatian, Matthias M. Weber> ;Pituitary. 2021 Mar 12
• 9 citations
  Adult growth hormone deficiency: Optimizing transition of care from pediatric to adult services
  Kevin C J Yuen, Craig A. Alter, Bradley S. Miller, Anthony Gannon, Nicholas A. Tritos, Susan L. Samson, Georgiana A Dobri, Kristine Kurtz, Frank Strobl, Nicky Kelepouris> ;Growth Hormone & IGF Research. 2021 Feb 1
• 9 citations
  Sensitivity and specificity of the macimorelin test for diagnosis of AGHD.
  Jose M. Garcia, Beverly M. K. Biller, Márta Korbonits, Vera Popovic, Anton Luger, Christian J. Strasburger, Philippe Chanson, Ronald S. Swerdloff, Christina Wang, Rosa...> ;Endocrine Connections. 2021 Jan 1
• 10 citations
  Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study.
  Moris Angulo, M. Jennifer Abuzzahab, Alberto Pietropoli, Vlady Ostrow, Nicky Kelepouris, Maithé Tauber> ;International Journal of Pediatric Endocrinology. 2020 Nov 10
• 2 citations
  Thorough QT/QTc Study Evaluating the Effect of Macimorelin on Cardiac Safety Parameters in Healthy Participants.
  Michael Lissy, Valentin Demmel, Richard Sachse, Nicola Ammer, Nicky Kelepouris, Vlady Ostrow> ;Clinical Pharmacology in Drug Development. 2020 Sep 22
• 8 citations
  Safety, tolerability, pharmacokinetics, and pharmacodynamics of macimorelin in healthy adults: Results of a single-dose, randomized controlled study.
  Beate Klaus, Richard Sachse, Nicola Ammer, Nicky Kelepouris, Vlady Ostrow> ;Growth Hormone & IGF Research. 2020 Jun 1
• 7 citations
  All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis.
  Nicholas A. Tritos, Anders F Mattsson, Greisa Vila, Beverly M. K. Biller, Anne Klibanski, Srinivas Rao Valluri, Judith Hey-Hadavi, Nicky Kelepouris, Camilo Jimenez> ;European Journal of Endocrinology. 2020 Mar 1
• 52 citations
  Long-Term Treatment with Pegvisomant as Monotherapy in Patients with Acromegaly: Experience from Acrostudy
  Pamela U. Freda, Murray B. Gordon, Nicky Kelepouris, Peter Jonsson, Maria Koltowska-Häggström, A. J. van der Lely> ;Endocrine Practice. 2015 Mar 1
• 92 citations
  Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial
  T. J. de Villiers, Arkadi Chines, Santiago Palacios, Paul Lips, A.Z. Sawicki, Amy B. Levine, C. Codreanu, Nicky Kelepouris, Jacques P. Brown> ;Osteoporosis International. 2011 Feb 1
• 132 citations
  Severe osteoporosis in men
  Nicky Kelepouris, Kristine D. Harper, Francis H. Gannon, Frederick S. Kaplan, John G. Haddad> ;Annals of Internal Medicine. 1995 Sep 15
• 2 citations
  Hemifacial spasm and osteitis deformans
  Edsel Ing, Peter J. Savino, Thomas M. Bosley, Robert C. Sergott, Nicky Kelepouris> ;American Journal of Ophthalmology. 1995 Mar 1
• Join now to see all

Lectures

• Career Development Workshop - Careers in Industry 
  ENDO 2019 - New Orleans, LA - 3/24/2019
• Neuroendocrinology and Pituitary 
  ENDO 2019 - New Orleans, LA - 3/23/2019